Shanghai Xuhui Central Hospital
Shanghai, Shanghai Municipality, 200031, China
NCT Number: NCT06083116
A single-center, single-arm, open-label, multi-dose, three-period study was conducted in healthy Chinese volunteers.
Looking for future studies?
Notify Me18 year–40 year
Male
Interventional
Phase 1
Shanghai, Shanghai Municipality, 200031, China
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Hydrochlorothiazide and Henagliflozin Proline
Time frame: Day 10, Day 14
Time frame: Day 10, Day 14
Time frame: Day 4, Day 14
Time frame: Day 4, Day 14
Time frame: Day 10, Day 14
Time frame: Day 10, Day 14
Time frame: Day 10, Day 14
Time frame: Day 4, Day 14
Time frame: Day 4, Day 14
Time frame: Day 4, Day 14
Time frame: Day 4, Day 14
Time frame: Day 4, Day 10, Day 14
Time frame: Day 10, Day 14
Time frame: Day 4, Day 14
Jiangsu HengRui Medicine Co., Ltd.
Industry
Evaluation of Drug-drug Interaction Between Henagliflozin Proline and Hydrochlorothiazide in Healthy Chinese Volunteers
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05147259
Diabetes in Adults
Jinan, Shandong, China
View Trial DetailsNCT07376044
Cardiovascular Diseases, Diabetes in Adults
Chicago, Illinois, United States
View Trial Details